Amanta Healthcare Limited (NSE:AMANTA)
India · Delayed Price · Currency is INR 108.56
-0.60 (-0.55%)
At close: Feb 12, 2026
Amanta Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 2,827 | 2,747 | 2,803 | 2,591 | 2,254 | 1,713 |
| 2,827 | 2,747 | 2,803 | 2,591 | 2,254 | 1,713 | |
Revenue Growth (YoY) | - | -2.01% | 8.19% | 14.94% | 31.61% | -7.09% |
Cost of Revenue | 930.18 | 948.23 | 1,051 | 1,018 | 767.95 | 495.25 |
Gross Profit | 1,897 | 1,799 | 1,752 | 1,574 | 1,486 | 1,218 |
Selling, General & Admin | 412.3 | 363.88 | 326.12 | 326.62 | 292.41 | 364.72 |
Other Operating Expenses | 862.62 | 838.28 | 851.33 | 715.02 | 657.78 | 468.09 |
Operating Expenses | 1,462 | 1,386 | 1,375 | 1,225 | 1,123 | 1,003 |
Operating Income | 435.62 | 412.7 | 377.6 | 348.57 | 363.49 | 214.66 |
Interest Expense | -217.98 | -269.66 | -323.97 | -343.85 | -430.58 | -380.93 |
Interest & Investment Income | 3.09 | 3.09 | 3.29 | 8.05 | 3.35 | 6.5 |
Currency Exchange Gain (Loss) | 0.68 | 0.68 | - | 18.98 | 3.17 | 2.82 |
Other Non Operating Income (Expenses) | -3.12 | -7.97 | -5.87 | -8.52 | -8.36 | -20.38 |
EBT Excluding Unusual Items | 218.29 | 138.84 | 51.05 | 23.23 | -68.93 | -177.33 |
Gain (Loss) on Sale of Investments | 5.01 | 5.01 | 2.48 | 1.33 | 1.31 | - |
Gain (Loss) on Sale of Assets | - | - | - | -4.64 | - | -1.53 |
Other Unusual Items | -24.44 | 1.85 | - | 5.34 | 685.23 | 0.67 |
Pretax Income | 200.23 | 147.07 | 53.89 | 26.9 | 617.87 | -177.56 |
Income Tax Expense | 63.55 | 42.06 | 17.56 | 48.01 | 79.06 | 40.78 |
Net Income | 136.68 | 105.01 | 36.33 | -21.11 | 538.82 | -218.34 |
Net Income to Common | 136.68 | 105.01 | 36.33 | -21.11 | 538.82 | -218.34 |
Net Income Growth | - | 189.02% | - | - | - | - |
Shares Outstanding (Basic) | 33 | 28 | 27 | 27 | 27 | 27 |
Shares Outstanding (Diluted) | 33 | 28 | 27 | 27 | 27 | 27 |
Shares Change (YoY) | - | 5.37% | -0.00% | - | 0.00% | - |
EPS (Basic) | 4.17 | 3.71 | 1.35 | -0.79 | 20.08 | -8.14 |
EPS (Diluted) | 4.17 | 3.71 | 1.35 | -0.79 | 20.08 | -8.14 |
EPS Growth | - | 174.81% | - | - | - | - |
Free Cash Flow | - | 258.46 | 446.62 | 362.9 | 535.62 | 199.08 |
Free Cash Flow Per Share | - | 9.14 | 16.65 | 13.53 | 19.96 | 7.42 |
Gross Margin | 67.10% | 65.48% | 62.51% | 60.73% | 65.94% | 71.09% |
Operating Margin | 15.41% | 15.02% | 13.47% | 13.45% | 16.12% | 12.53% |
Profit Margin | 4.83% | 3.82% | 1.30% | -0.81% | 23.90% | -12.75% |
Free Cash Flow Margin | - | 9.41% | 15.93% | 14.00% | 23.76% | 11.62% |
EBITDA | 601.77 | 578.47 | 548.72 | 513.77 | 527.72 | 384.06 |
EBITDA Margin | 21.28% | 21.06% | 19.57% | 19.83% | 23.41% | 22.42% |
D&A For EBITDA | 166.16 | 165.77 | 171.12 | 165.2 | 164.24 | 169.4 |
EBIT | 435.62 | 412.7 | 377.6 | 348.57 | 363.49 | 214.66 |
EBIT Margin | 15.41% | 15.02% | 13.47% | 13.45% | 16.12% | 12.53% |
Effective Tax Rate | 31.74% | 28.60% | 32.58% | 178.46% | 12.80% | - |
Revenue as Reported | 2,845 | 2,760 | 2,816 | 2,627 | 2,263 | 1,724 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.